Search
Customer Support

Contact our support team if you have any enquiries about any of our products

Call: (856) 848-8698

Email: info@akersbio.com

In Development: Rapid Breath Test for Diabetic Ketoacidosis (DKA)

Diabetic Ketoacidosis (DKA)

A single-use, non-invasive, breath device to rapidly screen for diabetic ketoacidosis (DKA). If approved, this developmental test will provide results in minutes using MPC® Biosensor Technology.

No capital equipment or specialized training is required.

Distributors: Contact Akers Bio to discuss potential distribution opportunities globally (if approved).

Specifications

  • Based on patented Micro Particle Catalyzed (MPC®) Biosensor technology
  • MPC® Biosensor Technology is an exciting development in biomedical science that rapidly determines biomarkers in breath condensate using newly-discovered catalytic agents and microparticles.

Note: This test is currently in development